Wall Street Week Ahead: Investors look beyond drug makers as hunt for Covid-19 treatment heats up
2/2 2/2
By David Randall
NEW YORK (Reuters) – Investors are diversifying bets in the healthcare sector, as the rush to develop treatments for Covid-19 has driven up prices for some pharmaceutical stocks.
A record 48% of fund managers are overweight healthcare stocks, a BofA survey showed,